Don't worry about a thing … every little thing gonna be all right (except for acral lentiginous melanoma)


      Bob Marley was a Jamaican singer, songwriter, and musician, considered one of the pioneers of reggae. In July 1977, he was diagnosed with acral lentiginous melanoma on his right great toe, which presented as a pigmented subungual lesion. Marley was advised to have his digit amputated, but he refused and opted for less invasive solutions. Unfortunately, he died at the age of 36 of metastatic disease in May 1981 after a 4-year battle with the disease. Marley has served as the posthumous poster child for skin cancer in people with skin of color for decades and has raised public awareness of this rare form of malignant melanoma.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinics in Dermatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Campbell C.
        Rastafari as Pan Africanism in the Caribbean and Africa.
        Afr J Pol Econ / Rev Afr D'Econ Pol. 1988; 2: 75-88
        • Soni V.
        Bob Marley's spiritual legacy (July 2, 2010; updated November 17, 2011).
        2020 (Available at: Accessed September 2)
        • Gooding C.
        A death by skin cancer? The Bob Marley story.
        April 15, 2011 (Available at: Accessed September 4, 2020)
        • Singh N.
        Decolonising dermatology: Why black and brown skin need better treatment.
        August 13, 2020 (Available at: Accessed September 3, 2020.)
        • Unlisted author
        His story: The life and legacy of Bob Marley.
        April 17, 2009 (Available at: Accessed September 4, 2020.)
        • Albreski D
        • Sloan SB.
        Melanoma of the feet: Misdiagnosed and misunderstood.
        Clin Dermatol. 2009; 27: 556-563
        • Williams R.
        Bob Marley's funeral, 21 May 1981: A day of Jamaican history.
        April 24, 2011 (Available at: Accessed September 17, 2020.)
        • Goydos JS
        • Shoen SL.
        Acral lentiginous melanoma.
        Cancer Treat Res. 2016; 167: 321-329
        • Nakamura Y
        • Fujisawa Y.
        Diagnosis and management of acral lentiginous melanoma.
        Curr Treat Options Oncol. 2018; 19: 42
        • Reed RJ.
        New Concepts in Surgical Pathology of the Skin.
        John Wiley & Sons, New York1976
        • Desai A
        • Ugorji R
        • Khachemoune A.
        Acral melanoma foot lesions. Part 1: Epidemiology, aetiology, and molecular pathology.
        Clin Exp Dermatol. 2017; 42: 845-848
        • Cust AE.
        Prognostic features for acral lentiginous melanoma.
        Br J Dermatol. 2018; 178: 311-312
        • Fernandez-Flores A
        • Cassarino DS.
        Histopathological diagnosis of acral lentiginous melanoma in early stages.
        Ann Diagn Pathol. 2017; 26: 64-69
        • Liu XK
        • Li J.
        Acral lentiginous melanoma.
        Lancet. 2018; 391: e21
        • Breslow A
        • Macht SD.
        Optimal size of resection margin for thin cutaneous melanoma.
        Surg Gynecol Obstet. 1977; 145: 691-692
        • Rebecca VW
        • Sondak VK
        • Smalley KS.
        A brief history of melanoma: From mummies to mutations.
        Melanoma Res. 2012; 22: 114-122
        • Handley WS.
        The pathology of melanotic growths in relation to their operative treatment.
        Lancet. 1907; (i:927-933 and i:996-1003W)
        • Lee C
        • Collichio F
        • Ollila D
        • Moschos S.
        Historical review of melanoma treatment and outcomes.
        Clin Dermatol. 2013; 31: 141-147
        • Gorantla VC
        • Kirkwood JM.
        State of melanoma: An historic overview of a field in transition.
        Hematol Oncol Clin North Am. 2014; 28: 415-435
        • Hill 2nd, GJ
        • Ruess R
        • Berris R
        • Philpott GW
        • Parkin P.
        Chemotherapy of malignant melanoma with dimethyl traizeno imidazole carboxamide (DITC) and nitrosourea derivatives (BCNU, CCNU).
        Ann Surg. 1974; 180: 167-174
        • Johnson RO
        • Metter G
        • Wilson W
        • Hill G
        • Krementz E.
        Phase I evaluation of DTIC (NSC-45388) and other studies in malignant melanoma in the Central Oncology Group.
        Cancer Treat Rep. 1976; 60: 183-187
        • Krementz ET
        • Ryan RF.
        Chemotherapy of melanoma of the extremities by perfusion: Fourteen years clinical experience.
        Ann Surg. 1972; 175: 900-917
        • Greenburg ZM.
        The top-earning dead celebrities of 2019.
        October 30, 2019 (Available at: Accessed September 4, 2020.)